Skip to main content
. 2017 Jun 13;157(3):478–487. doi: 10.1177/0194599817711378

Figure 6.

Figure 6.

Frequency of clinically relevant hearing loss in treated and untreated ears in unilaterally treated subjects (≥15 dB bone conduction in any 2 contiguous test frequencies from baseline). (a) AM-101 group (n = 109); (b) placebo group (n = 72). FUV, follow-up visit.